Tag: JAMA
Testing Individuals for Coronavirus Disease 2019 (COVID-19).
Potential Legal Liability for Withdrawing or Withholding Ventilators During COVID-19: Assessing the Risks and Identifying Needed Reforms.
Medical Student Education in the Time of COVID-19.
Older Clinicians and the Surge in Novel Coronavirus Disease 2019 (COVID-19).
FDA Trials Find Sunscreen Ingredients in Blood, but Risk Is Uncertain.
Sourcing Personal Protective Equipment During the COVID-19 Pandemic.
The Importance of Addressing Advance Care Planning and Decisions About Do-Not-Resuscitate Orders During Novel Coronavirus 2019 (COVID-19).
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
Additional treatments are needed for heart failure with reduced ejection fraction (HFrEF). Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be an effective treatment for patients with HFrEF, even those without diabetes.To […]
» Read moreEffect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial.
Bromodomain and extraterminal proteins are epigenetic regulators of gene transcription. Apabetalone is a selective bromodomain and extraterminal protein inhibitor targeting bromodomain 2 and is hypothesized to have potentially favorable effects […]
» Read moreEffect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
Additional treatments are needed for heart failure with reduced ejection fraction (HFrEF). Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be an effective treatment for patients with HFrEF, even those without diabetes.To […]
» Read moreA Framework for Rationing Ventilators and Critical Care Beds During the COVID-19 Pandemic.
Management of Critically Ill Adults With COVID-19.
Toward Universal Deployable Guidelines for the Care of Patients With COVID-19.
Antibodies in Infants Born to Mothers With COVID-19 Pneumonia.
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Coronavirus disease 2019 (COVID-19) is a pandemic with no specific therapeutic agents and substantial mortality. It is critical to find new treatments.To determine whether convalescent plasma transfusion may be beneficial […]
» Read morePostacute Care Preparedness for COVID-19: Thinking Ahead.
Preserving Clinical Trial Integrity During the Coronavirus Pandemic.
Convalescent Plasma to Treat COVID-19: Possibilities and Challenges.
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?
Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn.
Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19.
Nonalcoholic Steatohepatitis: A Review.
Nonalcoholic steatohepatitis (NASH) is the inflammatory subtype of nonalcoholic fatty liver disease (NAFLD) and is associated with disease progression, development of cirrhosis, and need for liver transplant. Despite its importance, […]
» Read moreDiagnostic Yield of Newborn Screening for Biliary Atresia Using Direct or Conjugated Bilirubin Measurements.
Treating biliary atresia in newborns earlier can delay or prevent the need for liver transplant; however, treatment typically occurs later because biliary atresia is difficult to detect during its early […]
» Read more